| Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia. (NCT05703802) | University Hospital Muenster | 2022-02-01 |
| Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (NCT05716334) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-06-15 |
| Hydroxychloroquine in ANCA Vasculitis Evaluation (NCT04316494) | Guy's and St Thomas' NHS Foundation Trust | 2020-12-17 |
| PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis (NCT04280601) | Christian Pagnoux | 2020-08-01 |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (NCT03482479) | University of Pennsylvania | 2019-02-04 |
| Journey of Patients With Vasculitis From First Symptom to Diagnosis (NCT03410290) | University of Pennsylvania | 2018-01-11 |
| VCRC Tissue Repository (NCT02967068) | University of Pennsylvania | 2016-11-01 |
| Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis (NCT02474888) | Centre Hospitalier Universitaire de Saint Etienne | 2015-09-15 |
| Impact of Vasculitis on Employment and Income (NCT02476292) | University of South Florida | 2015-06-01 |
| BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (NCT01598857) | Anthera Pharmaceuticals | 2014-12-01 |
| Low-dose Glucocorticoid Vasculitis Induction Study (NCT02198248) | Chiba University | 2014-10-01 |
| Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis (NCT02169219) | Massachusetts General Hospital | 2014-06-01 |
| VCRC Patient Contact Registry Patient-Reported Data Validation Study (NCT02190942) | University of South Florida | 2014-05-01 |
| Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis (NCT02126098) | Peking Union Medical College Hospital | 2014-05-01 |
| Rituximab Vasculitis Maintenance Study (NCT01697267) | Cambridge University Hospitals NHS Foundation Trust | 2013-04-01 |
| Pediatric Vasculitis Initiative (NCT02006134) | University of British Columbia | 2013-01-01 |
| Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis (NCT01731561) | Assistance Publique - Hôpitaux de Paris | 2012-11-16 |
| PRO Development for ANCA Associated Vasculitis (NCT01729624) | University of Oxford | 2012-09-01 |
| An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis (NCT01613599) | Genentech, Inc. | 2012-06-20 |
| Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study (NCT01586858) | Johns Hopkins University | 2012-05-01 |
| Educational Needs of Patients With Systemic Vasculitis (NCT02190929) | University of South Florida | 2012-03-01 |
| Vasculitis Illness Perception (VIP) Study (NCT02190916) | University of South Florida | 2011-10-01 |
| Alemtuzumab for ANCA Associated Refractory Vasculitis (NCT01405807) | Cambridge University Hospitals NHS Foundation Trust | 2011-02-01 |
| Reproductive Health in Men and Women With Vasculitis (NCT02176070) | University of South Florida | 2011-02-01 |
| American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis (NCT01066208) | University of Oxford | 2011-01-01 |
| One-Time DNA Study for Vasculitis (NCT01241305) | University of Pennsylvania | 2010-10-01 |
| Efficacy Study of Two Treatments in the Remission of Vasculitis (NCT00748644) | Assistance Publique - Hôpitaux de Paris | 2008-10-01 |
| Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis (NCT00315393) | University of Pennsylvania | 2006-04-01 |
| Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (NCT00307671) | Assistance Publique - Hôpitaux de Paris | 2005-07-01 |
| Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (NCT00104299) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides (NCT00307593) | Assistance Publique - Hôpitaux de Paris | 2004-05-01 |
| Anti-Cytokine Therapy for Vasculitis (NCT00753103) | University Hospital Birmingham NHS Foundation Trust | 2003-01-01 |
| CellCept in p-ANCA Vasculitis (NCT00405860) | Mayo Clinic | 2002-12-01 |
| Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides (NCT00430105) | Cambridge University Hospitals NHS Foundation Trust | 1998-02-01 |
| CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors (NCT00400075) | Hospices Civils de Lyon | 1996-07-01 |
| Plasma Exchange for Renal Vasculitis (NCT01408836) | Cambridge University Hospitals NHS Foundation Trust | 1995-03-01 |
| Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides (NCT00751517) | University of Parma | |